default author photo

Daniele Pignataro

Cardinal Massaia Hospital

Asti

Italy

SCHOLARLY PAPERS

3

DOWNLOADS

185

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Actionable Non-Small Cell Lung Cancer Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients with Advanced Lung Cancer (Epropa)

Number of pages: 19 Posted: 20 Mar 2024
University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, “Vito Fazzi” Hospital, Ospedale Giovanni Paolo II, Pederzoli Hospital-Peschiera del Garda, P.O.U. Villa Scassi Hospital - Medical Oncology, Mater Salutis Hospital AULSS9, “Scaligera” - Medical Oncology Unit, Humanitas Hospital Gradenigo, Ovidius University of Constanta, Renato Dulbecco University Hospital - Medical Oncology, Cardinal Massaia Hospital, Santo António University Hospital Center (CHUSA), University Hospital 12 de Octubre, Hospital Vall d’Hebron, University of Belgrade, Romanian Academy - Romanian Academy, University of Tirana, ASST Papa Giovanni XXIII, University of Florence, University of Athens, University Clinic of Respiratory and Allergic Diseases, San Giovanni di Dio Hospital,, University of Turin, University of Naples Federico II, University of Turin, University of Turin, University of Turin and University of Turin
Downloads 81 (796,622)

Abstract:

Loading...

Precision medicine, lung cancer, NGS, molecular biomarkers, targeted therapy, clinical trials

2.

Advanced-Stage Alk-Positive Non–Small-Cell Lung Cancer (Nsclc) Patients: Real-World Treatment Patterns and Outcomes from the Italian Biomarker Atlas Database

Number of pages: 24 Posted: 15 May 2025
“Vito Fazzi” Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, Università degli Studi di Udine - Azienda Sanitaria Universitaria Integrata di Udine, affiliation not provided to SSRN, Ospedale Giovanni Paolo II, affiliation not provided to SSRN, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Pederzoli Hospital-Peschiera del Garda, University of Pavia, University Hospital of Parma, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, University of Verona, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, University of Pisa, University Hospital Careggi, affiliation not provided to SSRN, Cardinal Massaia Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST Papa Giovanni XXIII, Università degli Studi di Genova, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, affiliation not provided to SSRN, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 65 (916,100)

Abstract:

Loading...

alectinib, ALK, Non-small-cell lung cancer, ALK TKIs, Lorlatinib

3.

Braf-Mutant Metastatic Non–Small-Cell Lung Cancer: Real World Data from the Italian Biomarker Atlas Database

Number of pages: 25 Posted: 12 Jun 2025
Ospedale Giovanni Paolo II, affiliation not provided to SSRN, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, affiliation not provided to SSRN, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Careggi University Hospital of Florence - Clinical Oncology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), “Vito Fazzi” Hospital, University of Verona - Hospital Trust, Cardinal Massaia Hospital, Pederzoli Hospital-Peschiera del Garda, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Pisa, ASST Papa Giovanni XXIII, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, affiliation not provided to SSRN, Università degli Studi di Genova, University of Florence, affiliation not provided to SSRN, University of Verona, affiliation not provided to SSRN, University of Pavia, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, University of Turin and affiliation not provided to SSRN
Downloads 39 (1,196,171)

Abstract:

Loading...

BRAF mutations, dabrafenib, trametinib, immunotherapy, BRAF V600E, NSCLC, real-world evidence.